Company Overview of Bicycle Therapeutics Limited
Bicycle Therapeutics Limited, a biotherapeutics company, focuses on developing highly constrained bicyclic peptides (bicycles) as novel class of therapeutics. The company is involved in developing a pipeline of bicycle molecules by using its proprietary bicyclic peptide technology that provide antibody-like affinity and selectivity in a much smaller chemically synthesized molecule. It applies its technology to various drug discovery projects, including oncology, ophthalmology, and other therapeutic areas through collaborative discovery partnerships with pharmaceutical companies. Bicycle Therapeutics Limited was founded in 2009 and is based in Cambridge, United Kingdom.
Babraham Research Campus
Cambridge, CB22 3AT
Founded in 2009
44 1223 497 415
Key Executives for Bicycle Therapeutics Limited
Bicycle Therapeutics Limited Key Developments
Similar Private Companies By Industry
|Autism Therapeutics Ltd.||Europe|
|United Therapeutics Europe, Ltd.||Europe|
|ProMetic BioSciences Ltd.||Europe|
Recent Private Companies Transactions
October 14, 2014
To contact Bicycle Therapeutics Limited, please visit www.bicycletherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.